Interaction of the common apolipoprotein C-III (APOC3-482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European atherosclerosis research study II (EARS-II)

Annals of Human Genetics

Volumn 65, Issue 3, 2001, Pages 237-243

  Jansen, H ^a   Waterworth, D M ^b,e   Nicaud, V ^c   Ehnholm, C ^d   Talmud, P J ^b,e  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e University St ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; FAT; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

ADULT; ALLELE; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; CLINICAL RESEARCH; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EUROPE; GLUCOSE TOLERANCE; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LOADING TEST; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PARAMETER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SYNDROME X;

ADULT; ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; GENOTYPE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPASE; LIPIDS; LIPOPROTEINS; LIVER; MALE; MICROVASCULAR ANGINA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRIGLYCERIDES;

EID: 0034946468     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0003480001008612     Document Type: Article

References (25)

1. Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins
2. Lipases and lecithin: Cholesterol acyltransferase in the control of lipoprotein metabolism
3. Alterations of VLDL composition during alimentary lipemia
4. Prediction of angiographic change in native human coronary arteries and aorto-coronary bypass grafts: Lipid and non-lipid factors
5. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor
6. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
7. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms
8. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism
9. Triglycerides, apo C3 and LpB:C3 and cardiovascular risk in Type II diabetes
10. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol
11. Chylomicron remnants: Hepatic receptors and metabolism
12. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography an a controlled trial of lovastatin
13. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II
14. A common C to T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients
15. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
16. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: The ECTIM study
17. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia
18. Banting lecture 1988. Role of insulin resistance in human disease
19. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against
20. The European Atherosclerosis Research Study (EARS): Design and objectives
21. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - The EARS II study (European Atherosclerosis Research Study)
22. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III
23. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter
24. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests
25. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver